Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
Posted On Friday, April 11, 2025
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
Posted On Friday, April 11, 2025
Vantage Biosciences Doses First Patient in Phase 2 Clinical Study of Oral VX-01 for Non-Proliferative Diabetic Retinopathy
Posted On Friday, April 11, 2025
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, April 10, 2025
Harvard Bioscience Announces CFO Transition
Posted On Thursday, April 10, 2025
Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
Posted On Thursday, April 10, 2025
Arcutis Announces Chief Financial Officer Transition
Posted On Thursday, April 10, 2025
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
Posted On Thursday, April 10, 2025
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
Posted On Thursday, April 10, 2025
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
Posted On Thursday, April 10, 2025
Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
Posted On Thursday, April 10, 2025
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
Posted On Thursday, April 10, 2025
Kapoor Wealth Partners Announces Inaugural Global Investment Summit and Grand Opening of Abu Dhabi Office on May 9, 2025
Posted On Thursday, April 10, 2025
Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.
Posted On Thursday, April 10, 2025
Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21
Posted On Thursday, April 10, 2025
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
Posted On Thursday, April 10, 2025
Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency
Posted On Thursday, April 10, 2025
BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
Posted On Thursday, April 10, 2025
Avalyn to Participate in Upcoming Investor Conference in April
Posted On Thursday, April 10, 2025
Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
Posted On Thursday, April 10, 2025
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
Posted On Thursday, April 10, 2025
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors
Posted On Thursday, April 10, 2025
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
Posted On Thursday, April 10, 2025
Glass House Brands and Eaze Partner to Launch PLUS Cannabis Gummies in Florida
Posted On Thursday, April 10, 2025
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025
Posted On Thursday, April 10, 2025

Print